{"transactions":[{"id":772602,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":46037,"kind":"person","name":"Raymon Heather","position":1,"cik":"0002028466","reported_name":"Raymon Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research and Development"}}],"security":"Common Stock","published_at":"2026-05-20T01:52:54.000Z","date":"2026-05-19","kind":"sale","planned":false,"acquired":false,"shares":3095,"price":9.0078,"value":27879.141,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Issuer has adopted a 'sell-to-cover' policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and release of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $9.0078, and the range of prices were between $8.7447 and $9.0104. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":148228,"source":{"system":"sec-edgar","filing":"0001193125-26-231510","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2028466/000119312526231510/ownership.xml","form_type":"4"}},{"id":897453,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":46037,"kind":"person","name":"Raymon Heather","position":1,"cik":"0002028466","reported_name":"Raymon Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research and Development"}}],"security":"Common Stock","published_at":"2026-02-18T23:51:15.000Z","date":"2026-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1521,"price":4,"value":6084.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards."}],"balance_after":151323,"source":{"system":"sec-edgar","filing":"0001193125-26-057674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2028466/000119312526057674/ownership.xml","form_type":"4"}},{"id":897452,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":46037,"kind":"person","name":"Raymon Heather","position":1,"cik":"0002028466","reported_name":"Raymon Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research and Development"}}],"security":"Common Stock","published_at":"2026-02-18T23:51:15.000Z","date":"2026-02-15","kind":"grant","planned":false,"acquired":true,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan."}],"balance_after":152844,"source":{"system":"sec-edgar","filing":"0001193125-26-057674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2028466/000119312526057674/ownership.xml","form_type":"4"}},{"id":971523,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":46037,"kind":"person","name":"Raymon Heather","position":1,"cik":"0002028466","reported_name":"Raymon Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research and Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-13T00:21:14.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10259,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares will vest on July 19, 2025, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":13.47,"expiration_date":"2034-05-01","underlying":"Common Stock","underlying_shares":10259},"source":{"system":"sec-edgar","filing":"0001193125-25-317983","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2028466/000119312525317983/ownership.xml","form_type":"4"}},{"id":971522,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":46037,"kind":"person","name":"Raymon Heather","position":1,"cik":"0002028466","reported_name":"Raymon Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research and Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-13T00:21:14.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11399,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Vesting is monthly over a 48-month period starting January 1, 2024 in equal monthly amounts."}],"balance_after":0,"derivative":{"exercise_price":5.18,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":11399},"source":{"system":"sec-edgar","filing":"0001193125-25-317983","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2028466/000119312525317983/ownership.xml","form_type":"4"}},{"id":971521,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":46037,"kind":"person","name":"Raymon Heather","position":1,"cik":"0002028466","reported_name":"Raymon Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research and Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-13T00:21:14.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares vested on February 22, 2022, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":5.01,"expiration_date":"2033-04-02","underlying":"Common Stock","underlying_shares":14819},"source":{"system":"sec-edgar","filing":"0001193125-25-317983","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2028466/000119312525317983/ownership.xml","form_type":"4"}},{"id":971520,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":46037,"kind":"person","name":"Raymon Heather","position":1,"cik":"0002028466","reported_name":"Raymon Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research and Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-13T00:21:14.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12539,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares vested on January 1, 2024, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":5.01,"expiration_date":"2033-04-02","underlying":"Common Stock","underlying_shares":12539},"source":{"system":"sec-edgar","filing":"0001193125-25-317983","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2028466/000119312525317983/ownership.xml","form_type":"4"}},{"id":971519,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":46037,"kind":"person","name":"Raymon Heather","position":1,"cik":"0002028466","reported_name":"Raymon Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research and Development"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-13T00:21:14.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18239,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares vested on October 22, 2021, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":5.14,"expiration_date":"2030-11-02","underlying":"Common Stock","underlying_shares":18239},"source":{"system":"sec-edgar","filing":"0001193125-25-317983","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2028466/000119312525317983/ownership.xml","form_type":"4"}},{"id":971518,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":46037,"kind":"person","name":"Raymon Heather","position":1,"cik":"0002028466","reported_name":"Raymon Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research and Development"}}],"security":"Common Stock","published_at":"2025-12-13T00:21:14.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":67253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units award granted under the Issuer's 2024 Equity Incentive Plan (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On December 12, 2025, the Issuer cancelled, pursuant to an option exchange, the options listed in Table II. In exchange for the cancelled options, the Reporting Person received the RSUs reported in Table I."}],"balance_after":106844,"source":{"system":"sec-edgar","filing":"0001193125-25-317983","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2028466/000119312525317983/ownership.xml","form_type":"4"}},{"id":998042,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":46037,"kind":"person","name":"Raymon Heather","position":1,"cik":"0002028466","reported_name":"Raymon Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research and Development"}}],"security":"Common Stock","published_at":"2025-11-18T01:39:25.000Z","date":"2025-11-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1375,"price":3.25,"value":4468.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards."}],"balance_after":39591,"source":{"system":"sec-edgar","filing":"0001193125-25-285009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2028466/000119312525285009/ownership.xml","form_type":"4"}},{"id":1064218,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":46037,"kind":"person","name":"Raymon Heather","position":1,"cik":"0002028466","reported_name":"Raymon Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research and Development"}}],"security":"Common Stock","published_at":"2025-08-19T00:15:11.000Z","date":"2025-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1639,"price":2.75,"value":4507.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards."}],"balance_after":40966,"source":{"system":"sec-edgar","filing":"0001415889-25-022223","document":"form4-08182025_080807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2028466/000141588925022223/form4-08182025_080807.xml","form_type":"4"}},{"id":1064217,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":46037,"kind":"person","name":"Raymon Heather","position":1,"cik":"0002028466","reported_name":"Raymon Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research and Development"}}],"security":"Common Stock","published_at":"2025-08-19T00:15:11.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":745,"price":2.13,"value":1586.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards."}],"balance_after":42605,"source":{"system":"sec-edgar","filing":"0001415889-25-022223","document":"form4-08182025_080807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2028466/000141588925022223/form4-08182025_080807.xml","form_type":"4"}},{"id":1238880,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":46037,"kind":"person","name":"Raymon Heather","position":1,"cik":"0002028466","reported_name":"Raymon Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research and Development"}}],"security":"Common Stock","published_at":"2025-02-28T22:15:16.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":33350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan."}],"balance_after":43350,"source":{"system":"sec-edgar","filing":"0001415889-25-006037","document":"form4-02282025_050211.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2028466/000141588925006037/form4-02282025_050211.xml","form_type":"4"}},{"id":1407897,"issuer":{"id":5404,"kind":"organization","name":"Artiva Biotherapeutics, Inc.","symbol":"ARTV"},"owners":[{"id":46037,"kind":"person","name":"Raymon Heather","position":1,"cik":"0002028466","reported_name":"Raymon Heather","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research and Development"}}],"security":"Common Stock","published_at":"2024-09-13T20:15:24.000Z","date":"2024-09-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001415889-24-023364","document":"form4-09132024_040911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2028466/000141588924023364/form4-09132024_040911.xml","form_type":"4"}}]}